Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 07 04:00PM ET
34.28
Dollar change
+26.86
Percentage change
361.99
%
IndexRUT P/E- EPS (ttm)-2.33 Insider Own18.30% Shs Outstand75.98M Perf Week327.97%
Market Cap2.74B Forward P/E- EPS next Y-2.03 Insider Trans-9.55% Shs Float65.38M Perf Month326.90%
Income-203.85M PEG- EPS next Q-0.57 Inst Own95.41% Short Float25.42% Perf Quarter335.03%
Sales0.00M P/S- EPS this Y-13.94% Inst Trans0.77% Short Ratio22.23 Perf Half Y136.41%
Book/sh1.67 P/B20.52 EPS next Y10.64% ROA-79.66% Short Interest16.62M Perf Year370.88%
Cash/sh2.38 P/C14.40 EPS next 5Y- ROE-121.29% 52W Range6.30 - 21.17 Perf YTD82.34%
Dividend Est.- P/FCF- EPS past 5Y8.79% ROI-105.14% 52W High61.93% Beta0.83
Dividend TTM- Quick Ratio6.04 Sales past 5Y-5.25% Gross Margin- 52W Low444.13% ATR (14)2.53
Dividend Ex-Date- Current Ratio6.04 EPS Y/Y TTM-2.48% Oper. Margin0.00% RSI (14)92.11 Volatility14.46% 9.60%
Employees150 Debt/Eq0.51 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price31.00
Option/ShortYes / Yes LT Debt/Eq0.45 EPS Q/Q-27.65% Payout- Rel Volume56.74 Prev Close7.42
Sales Surprise- EPS Surprise-1.63% Sales Q/Q- EarningsAug 08 BMO Avg Volume747.69K Price34.28
SMA20312.74% SMA50292.82% SMA200177.25% Trades Volume42,427,651 Change361.99%
Date Action Analyst Rating Change Price Target Change
Oct-07-24Reiterated H.C. Wainwright Buy $30 → $35
Mar-28-24Initiated Raymond James Strong Buy $30
Oct-25-23Upgrade Jefferies Hold → Buy $20
Apr-03-23Resumed Piper Sandler Overweight $26
Sep-19-22Resumed H.C. Wainwright Buy $30
Jul-12-22Initiated Truist Buy $20
Mar-23-22Initiated H.C. Wainwright Buy $24
Dec-22-21Downgrade Jefferies Buy → Hold $52 → $28
Nov-19-21Initiated Piper Sandler Overweight $56
Apr-26-21Resumed Credit Suisse Outperform $65
Oct-07-24 04:13PM
04:09PM
03:23PM
11:05AM
11:05AM
09:41AM Loading…
09:41AM
07:00AM
Sep-27-24 06:13AM
Sep-13-24 04:15PM
Sep-10-24 08:00AM
Sep-05-24 12:02AM
Sep-04-24 08:00AM
Sep-02-24 05:22PM
Aug-29-24 08:00AM
Aug-16-24 04:15PM
04:32AM Loading…
Aug-15-24 04:32AM
Aug-09-24 05:05AM
Aug-08-24 07:00AM
Jul-23-24 08:00AM
Jul-12-24 04:15PM
Jul-08-24 06:42PM
12:30PM
Jun-24-24 07:00AM
Jun-18-24 04:15PM
Jun-03-24 04:00PM
May-28-24 08:00AM
May-22-24 07:00AM
May-20-24 08:00AM
May-17-24 04:15PM
May-14-24 08:00AM
01:53PM Loading…
May-07-24 01:53PM
10:19AM
08:52AM
07:00AM
Apr-24-24 06:33AM
Apr-12-24 04:15PM
Mar-20-24 05:31AM
Mar-19-24 10:52PM
07:00AM
Mar-15-24 04:15PM
08:18AM
Feb-28-24 08:00AM
Feb-16-24 04:15PM
Feb-15-24 08:00AM
Feb-06-24 08:00AM
Jan-25-24 08:00AM
Jan-23-24 08:00AM
Jan-22-24 07:00AM
Jan-18-24 05:01PM
Jan-12-24 04:15PM
Jan-04-24 08:00AM
Jan-02-24 01:57PM
Dec-30-23 07:01PM
Dec-19-23 08:00AM
Dec-15-23 04:15PM
Dec-10-23 09:05AM
Nov-17-23 04:15PM
Nov-12-23 12:32PM
Nov-07-23 08:14AM
07:15AM
Nov-06-23 09:55AM
Nov-03-23 11:52PM
04:00PM
Nov-02-23 08:00AM
Oct-31-23 08:50AM
Oct-24-23 12:00PM
Oct-23-23 08:00AM
Oct-19-23 09:55AM
08:00AM
Oct-18-23 08:30AM
Oct-16-23 04:15PM
Oct-13-23 12:45PM
Oct-12-23 04:17PM
Oct-11-23 08:57PM
05:05PM
04:44PM
Sep-19-23 08:00AM
Sep-15-23 04:15PM
Sep-07-23 09:55AM
Aug-18-23 04:15PM
Aug-09-23 04:15PM
Aug-02-23 10:41AM
Jul-13-23 08:00AM
Jun-30-23 11:00AM
Jun-15-23 08:00AM
Jun-01-23 04:05PM
May-10-23 08:00AM
May-09-23 07:30AM
May-08-23 08:00AM
Apr-17-23 12:57PM
Apr-12-23 08:00AM
Apr-10-23 04:05PM
Mar-15-23 08:00AM
Mar-07-23 07:00AM
Mar-01-23 08:00AM
Feb-27-23 08:00AM
Feb-17-23 08:00AM
Feb-11-23 07:23AM
Feb-06-23 08:00AM
Jan-09-23 08:00AM
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Myles Edward HCOO & CFOOct 07 '24Sale26.56206,2405,477,546161,088Oct 07 09:52 PM
Sacco TraceyCHIEF COMMERCIAL OFFICEROct 07 '24Option Exercise10.0030,000300,00079,285Oct 07 09:03 PM
Sacco TraceyCHIEF COMMERCIAL OFFICEROct 07 '24Sale25.6230,000768,67749,285Oct 07 09:03 PM
AKKARAJU SRINIVASDirectorOct 07 '24Sale29.251,175,71334,385,6725,612,896Oct 07 08:55 PM
Marantz Jing L.CHIEF MEDICAL OFFICEROct 07 '24Option Exercise8.59109,375939,531182,230Oct 07 08:51 PM
Marantz Jing L.CHIEF MEDICAL OFFICEROct 07 '24Sale27.21109,3752,976,46872,855Oct 07 08:51 PM
AKKARAJU SRINIVASDirectorOct 07 '24Proposed Sale29.251,175,71334,385,725Oct 07 08:43 PM
Tracey SaccoOfficerOct 07 '24Proposed Sale25.6230,000768,693Oct 07 04:20 PM
Jing MarantzOfficerOct 07 '24Proposed Sale32.50120,0003,900,000Oct 07 04:18 PM
Edward MylesOfficerOct 07 '24Proposed Sale32.50243,4277,911,378Oct 07 04:16 PM
Qatanani MoCHIEF SCIENTIFIC OFFICERSep 16 '24Sale8.581,93616,611142,768Sep 19 08:15 AM
Parlavecchio CarynCHROAug 16 '24Sale9.331,45113,538151,988Aug 19 05:00 PM
Qatanani MoCHIEF SCIENTIFIC OFFICERJun 17 '24Sale8.982,31520,800144,704Jun 18 05:56 PM
Parlavecchio CarynCHROJun 17 '24Sale8.984,30538,680153,439Jun 18 05:55 PM
Myles Edward HCOO & CFOJun 17 '24Sale8.989,45884,978201,518Jun 18 05:54 PM
Ho JunlinGENERAL COUNSELJun 17 '24Sale8.984,69542,183204,076Jun 18 05:53 PM
Myles Edward HCOO & CFOFeb 16 '24Sale15.744,74474,686210,976Feb 21 06:13 PM
Qatanani MoCHIEF SCIENTIFIC OFFICERFeb 16 '24Sale15.742,51239,547147,019Feb 20 04:58 PM
Parlavecchio CarynCHROFeb 16 '24Sale15.743,75159,053157,744Feb 20 04:52 PM
Ho JunlinGENERAL COUNSELFeb 16 '24Sale15.743,48954,928208,771Feb 20 04:48 PM
Backstrom Jay T.CHIEF EXECUTIVE OFFICERFeb 16 '24Sale15.7411,614182,842352,671Feb 20 04:46 PM
Qatanani MoSVP AND HEAD OF RESEARCHJan 16 '24Sale15.932,00231,88978,816Jan 18 04:11 PM
Parlavecchio CarynCHROJan 16 '24Sale15.932,84945,381114,350Jan 18 04:08 PM
Myles Edward HCOO & CFOJan 16 '24Sale15.936,634105,670162,150Jan 18 04:07 PM
Ho JunlinGENERAL COUNSELJan 16 '24Sale15.934,18666,677154,405Jan 18 04:05 PM
Myles Edward HCOO & CFODec 29 '23Option Exercise4.8612,45960,551181,243Dec 29 07:13 PM
Myles Edward HCOO & CFODec 29 '23Sale18.8312,459234,633168,784Dec 29 07:13 PM
Qatanani MoSVP AND HEAD OF RESEARCHDec 14 '23Option Exercise10.008,43784,370105,480Dec 15 04:13 PM
Qatanani MoSVP AND HEAD OF RESEARCHDec 14 '23Sale18.1824,662448,44480,818Dec 15 04:13 PM
Myles Edward HCOO & CFODec 07 '23Option Exercise4.8624,914121,082193,698Dec 08 04:12 PM
Myles Edward HCOO & CFODec 07 '23Sale17.5324,914436,820168,784Dec 08 04:12 PM
Myles Edward HCOO & CFONov 02 '23Sale12.5135,007438,039168,784Nov 03 06:11 PM
AKKARAJU SRINIVASDirectorOct 16 '23Buy6.852,189,78115,000,0006,788,609Oct 18 05:46 PM
Samsara BioCapital GP, LLC10% OwnerOct 16 '23Buy6.852,189,78115,000,0006,788,609Oct 18 05:44 PM
Invus Public Equities, L.P.10% OwnerOct 12 '23Buy6.862,199,93115,086,73611,259,438Oct 16 05:46 PM